Quantcast

Latest Michael Wang Stories

2013-06-20 23:34:37

Latest results of Phase 2 study confirm high rate of response, remission In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL). The most recent interim findings of the 18-center Phase 2 study were published today in the New England Journal of Medicine. Previous interim findings were presented in...

2010-04-14 06:00:00

CHONGQING, China, April 14 /PRNewswire/ -- China Redstone Group, Inc. (OTC Bulletin Board: CGPI) ("China Redstone" or the "Company"), the largest private provider of cemetery products and services in Chongqing, China, announced today that it has appointed Mr. S. Michael Rudolph, a 30-year veteran in the financial services industry, and Mr. Lihua Zhang, an experienced hydropower industry executive and engineer with strong local government relations, to its board of directors effective April...

2009-12-07 14:17:48

Carfilzomib induces a response in 45 percent of patients and reduces neuropathy The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers reported today at the 51st Annual Meeting of the American Society of Hematology. The updated data from the 17-site study focuses on patients with relapsed or resistant multiple myeloma who have received one to...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related